# GF Securities

> GF Securities is a VC fund in Guangzhou backing Medical and Health Care. See 57 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Guangzhou, China
- Total investments: 57
- Last investment: Jun 2026
- Lead investor: 21%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/organization/1346686
- Website: http://en.gf.com.cn/

GF Securities is a VC fund in Guangzhou focused on Medical and Health Care. GF Securities provides securities broking and trading services. They offer securities brokerage, investment banking, wealth management, asset custody, and investment management services. They also conduct futures and finance businesses.

## Contacts

5 contacts available for GF Securities. Shizune tracks 3 team members at GF Securities. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/gf-securities?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $425k–$23M |
| Series B | $3M–$61M |
| Post-IPO Equity | $709k–$37M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 9 | 16% |
| Health Care | 9 | 16% |
| Biotechnology | 9 | 16% |
| Software | 7 | 12% |
| Manufacturing | 7 | 12% |

94 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Post-IPO Equity | 18 | 32% |
| Series B | 11 | 19% |
| Series A | 9 | 16% |
| Seed | 5 | 9% |
| Angel | 3 | 5% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 39 | 68% |
| United States | 7 | 12% |
| Canada | 4 | 7% |
| Japan | 1 | 2% |
| Israel | 1 | 2% |

6 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Hongwei Liu | CEO | 0 | https://shizune.co/investors/profile/hongwei-liu-5b25 |
| Tim Tu | Director, Global Markets | 0 | https://shizune.co/investors/profile/tim-tu |
| Zhang Ying | Fund Research Analyst | 1 | https://shizune.co/investors/profile/zhang-ying-5710 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Noitom Robotics | Noitom Robotics is an intelligent robot development company specializing in the sales, installation, and maintenance of industrial robots, as well as the sale of consumer robots and the research and development of intelligent robots. |  | Seed | Jun 16, 2026 |  |
| SuperMagnetic New Energy | SuperMagnetic New Energy is a cutting-edge innovation center and engineering incubator. |  | Angel | Jan 16, 2026 |  |
| Hurrichip | Hurrichip manufactures gallium nitride semiconductor lasers that is used during semiconductor testing. | $41.9M | Series B | Jul 01, 2025 |  |
| Sanyou Medical | Shanghai Sanyou Medical Co., Ltd is a corporation that is therapy innovation oriented and devotes to the R&D , manufacture and sales of independently innovative orthopedics implants . The headquarter is located in the Medical Apparatus Garden of Zhangjiang Hi-Tech Park , Shanghai . In September 2010 , a senior international management teamfinished the corporation restructuring and set up a brand new management mechanism to become a valuable and sustainable company . | $29.6M | Post-IPO Equity | Mar 13, 2025 |  |
| Xunchi Xunjie | Xunchi Xunjie is a new energy vehicle charging pile R&D and operation operator. | $21.8M | Series A | Jan 09, 2025 |  |
| Benlizu | Benlizu is a one-stop provider of office smart equipment leasing services, committed to offering corporations and government departments with low-cost and high-efficiency leasing options. |  | Seed | Dec 19, 2024 |  |
| Noematrix | Noematrix is an embodied intelligence company that specializes in innovative general robotic intelligence solutions and services. |  | Seed | Sep 06, 2024 |  |
| DFD | DFD is a high-tech enterprise engaged in the research, development, production and sales of high-performance inorganic fluorides. | $37.5M | Post-IPO Equity | Aug 17, 2023 |  |
| Regenex Corporation | Regenex Corporation is a pharmaceutical company that is involved in research and development, production, and sales of reproductive health medicines, chronic disease medicines, and external medicines. They implement GPS track management for marketing personnel and implement terminal standard methods for marketing. | $14M | Series C | Jun 16, 2023 |  |
| Value Partners | Value Partners Limited is an independent asset management firm, which specialises in traditional value-style investing. The company's investment coverage spans the Asia-Pacific region, with a core focus on the Greater China markets — a sector in which it has been rated as one of the top-performing fund managers by major rating agencies.Founded in 1993 by Cheah Cheng Hye and Yeh V-Nee, Value Partners Limited started business with only a few million US dollars in assets under management. Today the Value Partners Group is one of Hong Kong's largest home-grown investment managers.As at 31 October 2008, the unaudited assets under management of Value Partners Group were approximately US$3.1 billion. |  | Secondary Market | Jun 01, 2023 |  |

10 of 57 investments shown.

## Co-investors
- [Quark Venture](https://shizune.co/investors/profile/quark-venture) — VC Fund, 13 deals together
- [CITIC Securities](https://shizune.co/investors/profile/citic-securities) — VC Fund, 5 deals together
- [China Merchants Securities](https://shizune.co/investors/profile/china-merchants-securities) — VC Fund, 4 deals together
- [GF Xinde Investment Management](https://shizune.co/investors/profile/gf-xinde-investment-management) — VC Fund, 4 deals together
- [Guotai Junan Securities](https://shizune.co/investors/profile/guotai-junan-securities) — VC Fund, 4 deals together
- [Essence Securities](https://shizune.co/investors/profile/essence-securities) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Coinbase Ventures](https://shizune.co/investors/profile/coinbase-ventures) — VC Fund

### Similar stage
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund
- [KB Securities](https://shizune.co/investors/profile/kb-securities) — VC Fund
- [Frazier Healthcare Partners](https://shizune.co/investors/profile/frazier-healthcare-ventures) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Finance Investors in China](https://shizune.co/investors/finance-investors-china)
- [Finance VC Funds in China](https://shizune.co/investors/finance-vc-funds-china)

## FAQ

### What does GF Securities invest in?

GF Securities invests primarily in Medical, Health Care and Biotechnology startups, most often at Post-IPO Equity and Series B stage. Most of the 57 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is GF Securities's check size?

GF Securities typically joins rounds of $425k–$23M at Series A, $3M–$61M at Series B and $709k–$37M at Post-IPO Equity. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds GF Securities participates in.

### How do I contact GF Securities?

Public channels for GF Securities include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at GF Securities?

The team at GF Securities includes Hongwei Liu (CEO), Tim Tu (Director, Global Markets) and Zhang Ying (Fund Research Analyst). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co